Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products Continue to Hit the Market - Company Prepares for Strong Revenue Growth in 2nd Half of 2015
Jun 29, 2015, 10:27 ET
CORAL SPRINGS, Florida, June 29, 2015 /PRNewswire/ --
One of the fastest growing industries in the world is the nutritional supplement group, or more broadly known as Vitamins, Minerals and Supplements. It is projected that the industry may top $60 billion in 2021 according to the Nutritional Business Journal. Nutritional Supplement Companies, Retailers and Pharmaceutical Operations in focus today are Axxess Pharma Inc. (OTC: AXXE), Progressive Care Inc. (OTC: RXMD), USANA Health Sciences Inc. (NYSE: USNA), GNC Holdings Inc. (NYSE: GNC) and ARCA biopharma, Inc. (NASDAQ: ABIO)
Axxess Pharma Inc. (OTC: AXXE) a company that develops a variety of nutritional supplements and specialty pharmaceutical products through its subsidiary company AllStar Health Brands Inc., is pleased to announce management projects a strong finish to the second half of 2015. Currently, 2015 has been a year of aggressive marketing and global approvals to sell their all-natural Tapout supplements. Axxess Pharma is also proud to be a licensee for Tapout, the official fitness and training partner of WWE (Worldwide Wrestling Entertainment) (NYSE: WWE). To view the joint venture between Authentic Brands Group, LLC and WWE for Tapout, please click on the link: http://corporate.wwe.com/news/2015/abg-and-wwe-launch-tapout-joint-venture.
Read the full AXXE press release at http://www.financialnewsmedia.com/profiles/axxe.html
Axxess Pharma Management has now continued their growth by expanding their product line with new chocolate and peanut butter protein bars, pre-work out protein powders and new organic proteins. This latest product expansion comes at a time when supermarkets are preparing to sell Axxess Pharma's all-natural Tapout products in chain stores nationwide. In preparation for management's expansion into supermarkets, they have now reported they are in the final stage of completing their financial audits for up-listing to the more liquid OTCQB. Axxess Pharma anticipates audits will be completed within the next 30 days. Once audits are complete, management anticipates a quick up-listing to the OTCQB. There are many benefits to up-listing to the OTCQB. Some of these benefits include, improved ease of trading, opportunity for increased liquidity and recognition by Wall Street brokers and major Financial Institutions.
In other nutritional products & supplements news & recent events: Progressive Care Inc. (OTC: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME") and the supply of prescription medications to long term care facilities, announced late last week record pharmacy revenues for May 2015. April through May 2015 has provided the company with its strongest prescription revenues to date. With an average of 13,800 prescriptions filled per month, of which approximately 45% are newly authorized prescriptions, PharmCo reached over $2.3 million in revenues for the 2 month period. In May alone, PharmCo achieved $1.4 million in revenues. With only a 28% increase in filled prescriptions over the same period last year, the Company grew revenues by over 30%.
Imagine a tool specifically designed to help you take the first steps toward a healthier, happier life. That's exactly what USANA's (NYSE: USNA) True Health Assessment (THA) app is designed to do. The cutting-edge, portable health program provides a personalized approached to measuring your health and offers real-life solutions to help improve your lifestyle and nutrition. Read the full story at http://finance.yahoo.com/news/usanaincs-personalized-nutrition-program-wins-121500398.html
In a win for retailers GNC (NYSE: GNC) and Rite Aid (NYSE: RAD), a federal appeals court has affirmed the dismissal of multidistrict litigation over their advertisements for the popular joint-health supplement glucosamine chondroitin. They faced consumer allegations that the ads falsely claimed the supplements were scientifically proven to improve joint health, since independent studies showed they were no better than placebos... Read the full article at http://www.reuters.com/article/2015/06/19/health-supplements-ads-idUSL1N0Z52TR20150619
In other pharmaceutical developments & happenings: ARCA biopharma, Inc. (NASDAQ: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, recently announced the closing of the previously announced private placement financing with a select group of institutional investors, including lead investor Venrock, New Enterprise Associates (NEA), funds managed by Franklin Advisers, Inc., RA Capital Management, Tekla Life Sciences Investors and other institutional investors. ARCA received net proceeds of approximately $34 million from the sale of approximately 42 million units at a price of $0.8805 per unit. Each unit consists of one share of ARCA's common stock and a warrant to purchase 0.40 shares of common stock with an exercise price of $0.8716. The warrants have a term of seven years and become exercisable 180-days after the closing date.
OPKO Health, Inc. (NYSE: OPK) this past Friday announced the decision of the National Comprehensive Cancer Network (NCCN) to include 4Kscore® as a recommended test in the 2015 NCCN Guidelines for Prostate Cancer Early Detection. The panel concluded that the 4Kscore, as a blood test with greater specificity over the PSA test, is indicated for use prior to a first prostate biopsy or after a negative biopsy to assist patients and physicians in further defining the probability of high-grade cancer.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated three thousand dollars for news coverage of the current press release issued by Axxess Pharma Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Company: FN Media Group, LLC
Contact email: [email protected]
U.S. Phone: +1(954)345-0611
SOURCE FN Media Group LLC
Share this article